RxDoctor Payments Data

Chester Donnally, MD

Orthopaedic Surgery of the Spine · Addison, TXNPI 1730506072

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.7%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Evolution Spine, LLC at 30.8% of the total. Reporting peaked in 2023 at $63,232 and has fallen 80.1% since, to $12,559 in 2025.

$122,551in general payments, 2019–2025

Across 195 payments — averaging $628.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Evolution Spine, LLC$38K
  • Fuse Medical, Inc.$25K
  • Bioventus LLC$17K
  • Osseus Fusion Systems, LLC$10K
  • Globus Medical$10K
  • The Institute Of Musculoskeletal Science And Education$6K
  • plus $17K from 33 others

What the payments were for

  • Royalty or licence$29,77324%
  • Consulting fees$59,73449%
  • Speaking & faculty fees$19,52516%
  • Travel & lodging$6,7746%
  • Food & beverage$6,1085%
  • Education$6371%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$122,551 in reported general payments places this provider in the 80th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas

Medicare billing

Part B allowed, 2024
$326,997
Medicare patients
317
Services billed
1,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$589
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$520
Cyclobenzaprine Hcl34$515
Oxycodone Hcl57$399
Methocarbamol42$388
Gabapentin39$346
Methylprednisolone45$278
Pregabalin11$168
Tramadol Hcl26$125
Ondansetron Hcl14$51
Meloxicam28$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Addison

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →